PedAM
Pediatric Disease Annotations & Medicines
| Disease | polyneuropathy |
| Symptom | C0178650|gammopathy |
| Sentences | 9 |
| PubMedID- 24728842 | Fcγriiia (fcγriiia-v/v1158), as was suggested by a recent study in patients with a polyneuropathy associated with igm monoclonal gammopathy . |
| PubMedID- 26065001 | We have described a series of patients with polyneuropathy associated with igm monoclonal gammopathy and anti-mag antibodies. |
| PubMedID- 24781837 | In conclusion, polyneuropathy associated with igm monoclonal gammopathy and anti-ganglioside antibodies clinically resembles anti-mag neuropathy. |
| PubMedID- 24487381 | Objective: to investigate the association of fcgammariia and fcgammariiia polymorphisms with the response to rituximab treatment in a cohort of patients with polyneuropathy associated with igm monoclonal gammopathy (pnp-igm) with and without antimyelin-associated glycoprotein antibodies. |
| PubMedID- 26028199 | A case of sensory ataxic axonal polyneuropathy with igglambda monoclonal gammopathy successfully treated with intravenous immunoglobulin therapy. |
| PubMedID- 22399147 | Unfortunately, polyneuropathy associated with monoclonal gammopathy is often refractory to treatment. |
| PubMedID- 25572169 | Anti-mag neuropathy is a very rare form of acquired polyneuropathy associated with igm monoclonal gammopathy of undetermined significance (mgus). |
| PubMedID- 23095652 | The prevalence of polyneuropathy in patients with monoclonal gammopathy of undetermined significance (mgus) has been reported to be 10-50%. |
| PubMedID- 20015874 | This monoclonal gammopathy is frequently associated with polyneuropathy and antibodies against myelin protein zero, whereas the role of the t cells remains largely unknown. |
Page: 1